Potential FDA Approval for Novavax Vaccine Sends Stock Even Higher
[ad_1] Politico said the FDA could approve Novavax’s two-dose Covid-19 vaccine as soon as today The shares of Novavax, Inc. (NASDAQ:NVAX) are up 2.2% at $71.30 this morning, after Politico…